Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man

Human and Experimental Toxicology

Volumn 27, Issue 4, 2008, Pages 281-288

  Jakasa, I ^a   Kezic, S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Animal model; Dermal absorption; In vitro; In vivo; Skin

Indexed keywords

CELL MEMBRANE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; NONHUMAN; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; REVIEW; SKIN ABSORPTION; SKINFOLD THICKNESS; ANIMAL; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PREDICTION AND FORECASTING; RISK ASSESSMENT; SKIN;

ANIMALIA; RATTUS;

XENOBIOTIC AGENT;

ADMINISTRATION, CUTANEOUS; ANIMALS; HUMANS; MODELS, ANIMAL; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SKIN; SKIN ABSORPTION; XENOBIOTICS;

EID: 52649141568     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327107085826     Document Type: Review

References (53)

1. European Commission. Guidance document on dermal absorption directorate E1-plant health. Sanco/333/2000, Rev. 6, 2002.
2. ECB technical guidance document on risk assessment in support of commission directive 93/67/EEC on risk assessments for new substances and commission regulation (EC) No. 1488/94 on risk assessment for existing substance. EUR 20418 EN/1.
3. Howes D Guy R Hadgraft J Heylings J Hoeck U Kemper F. Methods for assessing percutaneous absorption. ECVAM workshop report 13. Altern Lab Anim 1996 ; 24: 81-106.
4. Diembeck W Beck H Benech-Kieffer F Courtellemont P Dupuis J Lovell W. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem Toxicol 1999 ; 37: 191-205.
5. OECD. OECD guideline for the testing of chemicals. Skin absorption: in vitro method. 428. Adopted: 13 April 2004. Paris: Organisation for Economic Co-operation and Development; 2004.
6. SCCNFP. Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients. Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers, (SCCNFP/0970/06); 2006.
7. USEPA. In vitro dermal absorption rate testing of certain chemicals of interest to the occupational safety and health administration; final rule. Fed Regist 2004 ; 69: 22402-22441.
8. OECD. Test guideline program. Percutaneous absorption testing; is there a way to consensus? OECD document ENV/JM/TG (2000). Paris, France 2000.
9. Zendzian RP. Dermal absorption of pesticides in the rat. Am Ind Hyg Assoc J 2000 ; 61: 473-483.
10. EDETOX. Quality of life and management of living resources. Final report for dissemination. European Commission, evaluation and predictions of dermal absorption 2004.
11. Williams FM. EDETOX. Evaluations and predictions of dermal absorption of toxic chemicals. Int Arch Occup Environ Health 2004 ; 77: 150-151.
12. Kezic S. Methods for measuring in vivo percutaneous absorption in humans. Hum Exp Toxicol 2008 (this issue).
13. Criteria Environmental Health. 235. Dermal absorption, World Health Organization. Geneva, Switzerland, 2006.
14. Jakasa I Mohammadi N Krüse J Kezic S. Percutaneous absorption of neat and aqueous solutions of 2-butoxyethanol in volunteers. Int Arch Occup Environ Health 2004 ; 77: 79-84.
15. Kezic S Janmaat A Krüse J Monster AC Verberk MM. Percutaneous absorption of m-xylene vapour in volunteers during pre-steady and steady state. Toxicol Lett 2003 ; 153: 273-282.
16. Yourick JJ Koenig ML Yourick DL Bronaugh RL. Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption? Toxicol Appl Pharmacol 2004 ; 195: 309-320.
17. Williams FM. In vitro studies-how good are they at replacing in vivo studies for measurement of skin absorption? Environ Toxicol Pharmacol 2006 ; 21: 199-203.
18. Bronaugh RL Collier SW. Protocol for in vitro percutaneous absorption studies. In: RL Bronaugh HI Maibach, (ed), In vitro percutaneous absorption: principles, fundamentals, and applications. Boston: CRC Press ; 1991. p. 237-241.
19. Clowes HM Scott RC Heylings JR. Skin absorption: flow-through or static diffusion cells. Toxicol In Vitro 1994 ; 8: 827-830.
20. Van de Sandt JJM van Burgsteden JA Cage S Carmichael PL Dick I Kenyon S. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharmacol 2004 ; 39: 271-281.
21. Chilcott RP. Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials. J Pharm Sci 2005 ; 94: 632-638.
22. Bronaugh RL Hood HL Kraeling MEK Yourick JJ. Determination of percutaneous absorption by in vitro techniques. In: RL Bronaugh HI Maibach, (eds), Percutaneous absorption: drugs-cosmetics-mechanisms-methodology, 3rd ed. New York: Marcel Dekker ; 1999.
23. Cross SE Anissimov YG Magnusson BM Roberts MS. Bovine-serum-albumin- containing receptor phase better predicts transdermal absorption parameters for lipophilic compounds. J Invest Dermatol 2003 ; 120: 589-591.
24. DeLange J Vaneck P Bruijnzeel PLB Elliott GR. The rate of percutaneous permeation of xylene, measured using the perfused pig ear model, is dependent on the effective protein concentration in the perfusing medium. Toxicol Appl Pharmacol 1994 ; 127: 298-305.
25. Sartorelli P Anderson HR Angerer J Corish J Drexler H Göen T. Percutaneous penetration studies for risk assessment. Environ Toxicol Pharmacol 2000 ; 8: 133-152.
26. Wilkinson SC Williams FM. Effects of experimental conditions on absorption of glycol ethers through human skin in vitro. Int Arch Occup Environ Health 2002 ; 75: 519-527.
27. Ramsey JD Woollen BH Auton TR Scott RC. The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluazifop-butyl) through rat and human skin. Fundam Appl Toxicol 1994 ; 23: 230-236.
28. Vecchia BE Bunge AL. Skin absorption databases and predictive equations. In: Guy, R, Hadgraft, J, (eds), Transdermal drug delivery, 2nd ed. New York: Marcel Dekker; 2003 ; p. 57-141 (Drugs and the Pharmaceutical Sciences Vol. 123).
29. Wilkinson SC Maas WJ Nielsen JB Greaves LC van de Sandt JJ Williams FM. Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies. Int Arch Occup Environ Health 2006 ; 79: 405-413.
30. Kasting GB Filloon TG Francis WR Meredith MP. Improving the sensitivity of in vitro skin penetration experiments. Pharm Res 1994 ; 11: 1747-1754.
31. Wilkinson SC Williams FM. Effects of experimental conditions on absorption of glycol ethers through human skin in vitro. Toxicol In Vitro 2005 ; 19: 813-822.
32. Cnubben NH Elliott GR Hakkert BC Meuling WJ van de Sandt JJ. Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol. Regul Toxicol Pharmacol 2002 ; 35: 198-208.
33. Van de Sandt JJM Meuling WJA Elliott GR Cnubben NHP Hakkert B. Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur. Toxicol Sci 2000 ; 58: 15-22.
34. Bronaugh RL Stewart RF Congdon ER. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 1982 ; 62: 481-488.
35. Wester RC Maibach HI. In vivo animal models for percutaneous absorption. In: RL Bronaugh HI Maibach, (eds), Percutaneous absorption, 2nd ed. New York: Marcel Dekker ; 1989.
36. Wester RC Noonan PK. Relevance of animal models for percutaneous absorption. Int J Pharm 1980 ; 7: 99-110.
37. Vecchia BE Bunge AL. Animal models: a comparison of permeability coefficients for excised skin from humans and animals. In: JE Riviere, (ed), Dermal absorption models in toxicology and pharmacology. Boca Raton: Taylor & Francis ; 2005.
38. Simon GA Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview. Skin Pharmacol Appl Skin Physiol 2000 ; 13: 229-234.
39. Beck H Bracher M Bartnik FG. Percutaneous absorption of hair dyes: an interlaboratory comparison of in vivo and in vitro data with rat and pig. In Vitro Toxicol 1994 ; 7: 305-312.
40. Davies DJ Ward RJ Heylings JR. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol In Vitro 2004 ; 18: 351-358.
41. Benech-Kieffer F Wegrich P Schwarzenbach R Klecak G Weber T Leclaire J. Percutaneous absorption of sunscreens in vitro: interspecies comparison, skin models and reproducibility aspects. Skin Pharmacol Appl Skin Physiol 2000 ; 13: 324-335.
42. Van Ravenzwaay B Leibold E. A comparison between in vitro rat and human and in vivo rat skin absorption studies. Hum Exp Toxicol 2004 ; 23: 421-430. (Pubitemid 39317445)
43. Moss T Howes D Williams FM. Percutaneous penetration and dermal metabolism of triclosan (2,4,4'-trichloro-2'-hydroxydiphenyl ether). Food Chem Toxicol 2000 ; 38: 361-370.
44. Lockley DJ Howes D Williams FM. Percutaneous penetration and metabolism of 2-ethoxyethanol. Toxicol Appl Pharmacol 2000 ; 180: 74-82.
45. Roper CS Simpson AG Madden S Serex TL Biesemeier JA. Absorption of [14C]-tetrabromodiphenyl ether (TeBDE) through human and rat skin in vitro. Drug Chem Toxicol 2006 ; 29: 289-301.
46. Kenyon SH Bhattacharyya J Benson CJ Carmichael PL. Percutaneous penetration and genotoxicity of 4,4'-methylenedianiline through rat and human skin in vitro. Toxicology 196: 65-75.
47. Kenyon S Carmichael PL Khalaque S Panchal S Waring R Harris R. The passage of trimethylamine across rat and human skin. Food Chem Toxicol 2004 ; 42: 1619-1628.
48. Traynor MJ Wilkinson SC Williams FM. The influence of water mixtures on the dermal absorption of glycol ethers. Toxicol Appl Pharmacol 2007 ; 218: 128-134.
49. Van Ravenzwaay B Leibold E. The significance of in vitro rat skin absorption studies to human risk assessment. Toxicol In Vitro 2004 ; 18: 219-225. (Pubitemid 38125202)
50. Hueber-Becker F Nohynek GJ Meuling WJ Benech-Kieffer F Toutain H. Human systemic exposure to a [14C]-para-phenylenediamine-containing oxidative hair dye and correlation with in vitro percutaneous absorption in human or pig skin. Food Chem Toxicol 2004 ; 42: 1227-1236.
51. Benech-Kieffer F Meuling WJA Leclerc C Roza L Leclaire J Nohynek G. Percutaneous absorption of 14C-Mexoryl SX-in human volunteers. Comparison with in vitro Data. Skin Pharmacol Appl Skin Physiol 2003 ; 16: 343-355.
52. Dick IP Blain PG Williams FM. The percutaneous absorption and skin distribution of lindane in man. I. In vivo studies. Hum Exp Toxicol 1997 ; 16: 645-651.
53. Dick IP Blain PG Williams FM. The percutaneous absorption and skin distribution of lindane in man. II. In vitro studies. Hum Exp Toxicol 1997 ; 16: 652-657.